EndeavorRx— 510(k) K231337

Substantially Equivalent

Akili Interactive Labs, Inc.

FDA 510(k) clearance K231337 for EndeavorRx, Substantially Equivalent on 2023-12-13. Applicant: Akili Interactive Labs, Inc..

Clearance details

Applicant: Akili Interactive Labs, Inc.
Product code: Code QFT
Advisory panel: Obstetrics/Gynecology
Date received: 2023-05-08
Decision date: 2023-12-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Boston,, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.